dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
Published 12 years ago • 502 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
1:08
dr. michael rotkowitz on ipilimumab plus dacarbazine for metastatic melanoma
-
1:25
dr. michael rotkowitz on dacarbazine plus ipilimumab in patients with metastatic melanoma
-
2:16
dr. rodabe n. amaria on dabrafenib plus trametinib in melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:12
dr. michael rotkowitz defines personalized medicine
-
4:36
practical experience with dabrafenib/trametinib in ncslc
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
1:37
dr. arkenau on dabrafenib combined with trametinib for braf-mutated melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
1:24
dr. algazi on benefit of continuous dabrafenib/trametinib dosing in braf melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:08
dr. rotkowitz describes challenges facing immunotherapy
-
1:32
dr. antoni ribas on the benefits of mapk inhibition with dabrafenib and trametinib
-
4:37
tafinlar® (dabrafenib) mekinist® (trametinib) mechanism of action for advanced melanoma
-
1:33
dr. paul chapman on braf and mek inhibitor combination for advanced melanoma